Proper care of patients with myelodysplastic syndrome (MDS) is critically dependent on a correct diagnosis. Physicians at Memorial Sloan-Kettering are expert at distinguishing MDS from the many other conditions with which it is often confused. Physicians here employ an array of sophisticated technologies -- such as cytogenetic, molecular, and immunohistochemistry studies -- to characterize blood and bone marrow cells precisely and to identify the most appropriate course of treatment for individual patients.
Memorial Sloan-Kettering's Hematology Disease Management Team provides comprehensive, multidisciplinary care to more than 100 new MDS patients each year. The team includes hematologists, pathologists, cytogeneticists, blood bank physicians, bone marrow transplant physicians, and other specialists who are internationally recognized for their expertise in the field. Memorial Sloan-Kettering has been designated a Center of Excellence by the Myelodysplastic Syndromes Foundation.
Select from the list below to learn more about our hematologists, their education, training, board certifications, current publications, and specific areas of expertise.
